影响肝细胞癌切除术后复发和预后因素的研究进展
Progress on Factors Affecting the Recurrence and Prognosis of Hepatocellular Carcinoma after Resection
DOI: 10.12677/ACM.2022.123239, PDF,   
作者: 刘南秋, 龚建平:重庆医科大学附属第二医院肝胆外科,重庆
关键词: 肝细胞癌切除复发预后Hepatocellular Carcinoma Resection Recurrence Prognosis
摘要: 肝细胞癌是全球癌症死亡率第三的癌症。肝切除术是治疗肝细胞癌的主要治疗方式,但术后的高复发率严重影响了患者预后。肝细胞癌肝切除术后的复发和预后受多种因素影响,如何评估和预测成为了研究热点。近年来,人们发现术前肝功能、乙肝病毒感染、肿瘤大小、术后干预治疗等措施都可能对术后复发和预后有着影响。本文将对影响肝细胞癌切除术后复发和预后的因素进行综述。
Abstract: Hepatocellular carcinoma (HCC) is the third most common cause of cancer-associated death worldwide. Hepatectomy is the main treatment for hepatocellular carcinoma, but the high recurrence rate seriously affects the prognosis of patients. The recurrence and prognosis of hepatocellular carcinoma after hepatectomy are affected by many factors. How to evaluate and predict it has become a notable subject. In recent years, it has been found that preoperative liver function, infection of hepatitis B virus, tumor size, postoperative intervention therapy and other factors may have an effect on the recurrence and prognosis of patients with HCC. This article will review the studies reporting the factors which affect the recurrence and prognosis of hepatocellular carcinoma after resection.
文章引用:刘南秋, 龚建平. 影响肝细胞癌切除术后复发和预后因素的研究进展[J]. 临床医学进展, 2022, 12(3): 1663-1670. https://doi.org/10.12677/ACM.2022.123239

参考文献

[1] Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Liu, Y., et al. (2016) Preoperative Inflammation-Based Markers Predict Early and Late Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy. Hepatobiliary & Pancreatic Diseases International, 15, 266-274. [Google Scholar] [CrossRef
[3] 陈康, 等. 性别对肝细胞癌患者肝切除术后预后的影响[J]. 中华肝胆外科杂志, 2020, 26(5): 330-334.
[4] Bhanu, J.S., et al. (2020) Prognostic Factors and Survival Outcomes of Surgical Resection of Huge Hepatocellular Carcinomas. Journal of Gastrointestinal Cancer, 51, 250-253. [Google Scholar] [CrossRef] [PubMed]
[5] Shimada, S., et al. (2020) Prognoses, Outcomes, and Clinicopathological Characteristics of Very Elderly Patients with Hepatocellular Carcinoma Who Underwent Hepatectomy. World Journal of Surgical Oncology, 18, 122. [Google Scholar] [CrossRef] [PubMed]
[6] Zhou, L., et al. (2020) Risk Factors of Recurrence and Poor Survival in Curatively Resected Hepatocellular Carcinoma with Microvascular Invasion. Advances in Clinical and Experimental Medicine, 29, 887-892. [Google Scholar] [CrossRef] [PubMed]
[7] Zhou, L., et al. (2018) Prognostic Value of ALT, AST, and AAR in Hepatocellular Carcinoma with B-Type Hepatitis-Associated Cirrhosis after Radical Hepatectomy. Clinical Laboratory, 64, 1739-1747. [Google Scholar] [CrossRef
[8] Suh, S.W. and Choi, Y.S. (2019) Influence of Liver Fibrosis on Prognosis after Surgical Resection for Resectable Single Hepatocellular Carcinoma. ANZ Journal of Surgery, 89, 211-215. [Google Scholar] [CrossRef] [PubMed]
[9] Marasco, G., et al. (2019) Role of Liver and Spleen Stiffness in Predicting the Recurrence of Hepatocellular Carcinoma after Resection. Journal of Hepatology, 70, 440-448. [Google Scholar] [CrossRef] [PubMed]
[10] Chen, H.L., Chen, Y.-H., Du, L., Song, Y.-P. and Zhu, B. (2021) Elevated Serum Alpha-Fetoprotein Levels Are Associated with Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection: A Systematic Review and Meta-Analysis. Arab Journal of Gastroenterology, 22, 12-22. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, B., et al. (2019) Platelet Activation Status in the Diagnosis and Postoperative Prognosis of Hepatocellular Carcinoma. Clinica Chimica Acta, 495, 191-197. [Google Scholar] [CrossRef] [PubMed]
[12] Hung, H.C., et al. (2017) Impact of Neutrophil to Lymphocyte Ratio on Survival for Hepatocellular Carcinoma after Curative Resection. Journal of Hepato-Biliary-Pancreatic Sciences, 24, 559-569. [Google Scholar] [CrossRef] [PubMed]
[13] Xi, Z.F., et al. (2019) Expression of IL-26 Predicts Prognosis of Patients with Hepatocellular Carcinoma after Surgical Resection. Hepatobiliary & Pancreatic Diseases International, 18, 242-248. [Google Scholar] [CrossRef] [PubMed]
[14] 戚超英, 等. 输血和输血量对肝细胞癌根治切除术后复发的影响[J]. 中华普通外科学文献(电子版), 2021, 15(5): 321-325.
[15] Wada, H., et al. (2018) Perioperative Allogenic Blood Transfusion Is a Poor Prognostic Factor after Hepatocellular Carcinoma Surgery: A Multi-Center Analysis. Surgery Today, 48, 73-79. [Google Scholar] [CrossRef] [PubMed]
[16] Harada, N., et al. (2015) Blood Transfusion Is Associated with Recurrence of Hepatocellular Carcinoma after Hepatectomy in Child-Pugh Class A Patients. World Journal of Surgery, 39, 1044-1051. [Google Scholar] [CrossRef] [PubMed]
[17] Peng, T., et al. (2018) No Impact of Perioperative Blood Transfusion on Prognosis after Curative Resection for Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Clinical and Translational Oncology, 20, 719-728. [Google Scholar] [CrossRef] [PubMed]
[18] Shi, F., et al. (2019) Is Anatomical Resection Necessary for Early Hepatocellular Carcinoma? A Single Institution Retrospective Experience. Future Oncology, 15, 2041-2051. [Google Scholar] [CrossRef] [PubMed]
[19] Su, C.M., Chou, C.-C., Yang, T.-H. and Lin, Y.-J. (2021) Comparison of Anatomic and Non-Anatomic Resections for Very Early-Stage Hepatocellular Carcinoma: The Importance of Surgical Resection Margin Width in Non-Anatomic Resection. Surgical Oncology, 36, 15-22. [Google Scholar] [CrossRef] [PubMed]
[20] Lin, N., et al. (2020) Does the Intermittent Pringle Maneuver Affect the Recurrence Following Surgical Resection for Hepatocellular Carcinoma? A Systematic Review. PLoS ONE, 15, e0229870. [Google Scholar] [CrossRef] [PubMed]
[21] Xie, Q.S., et al. (2021) Systematic Review of Outcomes and Meta-Analysis of Risk Factors for Prognosis after Liver Resection for Hepatocellular Carcinoma without Cirrhosis. Asian Journal of Surgery, 44, 36-45. [Google Scholar] [CrossRef] [PubMed]
[22] Saito, R., et al. (2019) Prognostic Factors for Post-Recurrent Survival in Hepatocellular Carcinoma after Curative Resection. Anticancer Research, 39, 3033-3038. [Google Scholar] [CrossRef] [PubMed]
[23] Shinkawa, H., et al. (2020) Tumor Size Drives the Prognosis after Hepatic Resection of Solitary Hepatocellular Carcinoma without Vascular Invasion. Journal of Gastrointestinal Surgery, 24, 1040-1048. [Google Scholar] [CrossRef] [PubMed]
[24] Dai, C.Y., et al. (208) Impact of Tumor Size on the Prognosis of Hepatocellular Carcinoma in Patients Who Underwent Liver Resection. Journal of the Chinese Medical Association, 81, 155-163. [Google Scholar] [CrossRef] [PubMed]
[25] Li, J., et al. (2021) Risk Factors and Clinical Outcomes of Extrahepatic Recurrence in Patients with Post-Hepatectomy Recurrent Hepatocellular Carcinoma. ANZ Journal of Surgery, 91, 1174-1179. [Google Scholar] [CrossRef] [PubMed]
[26] Shimada, S., et al. (2020) Long-Term Prognostic Factors of Patients with Hepatocellular Carcinoma Who Survive over 10 Years after Hepatectomy. Journal of Surgical Oncology, 121, 1209-1217. [Google Scholar] [CrossRef] [PubMed]
[27] Li, M., et al. (2019) Risk Factors and Prognosis of Patients with Recurrent Hepatocellular Carcinoma Who Undergo Liver Re-Resections. European Journal of Surgical Oncology, 45, 1684-1690. [Google Scholar] [CrossRef] [PubMed]
[28] 何旭昶, 等. 微血管侵犯分级对肝细胞癌行根治性肝切除术后早期复发的预测价值[J]. 临床肝胆病杂志, 2020, 36(8): 1757-1762.
[29] Han, J., et al. (2019) The Impact of Resection Margin and Microvascular Invasion on Long-Term Prognosis after Curative Resection of Hepatocellular Carcinoma: A Multi-Institutional Study. HPB (Oxford), 21, 962-971. [Google Scholar] [CrossRef] [PubMed]
[30] Erstad, D.J. and Tanabe, K.K. (2019) Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. Annals of Surgical Oncology, 26, 1474-1493. [Google Scholar] [CrossRef] [PubMed]
[31] Matsumoto, M., et al. (2021) Treatment of Intrahepatic Recurrence after Hepatectomy for Hepatocellular Carcinoma. Annals of Gastroenterological Surgery, 5, 538-552. [Google Scholar] [CrossRef] [PubMed]
[32] Li, L., Li, B. and Zhang, M. (2020) Postoperative Adjuvant Transarterial Chemoembolization Improves the Prognosis of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Systematic Review and Meta-Analysis. Acta Radiologica, 61, 723-731. [Google Scholar] [CrossRef] [PubMed]
[33] Feng, A.L., et al. (2021) Repeated Postoperative Adjuvant TACE after Curative Hepatectomy Improves Outcomes of Patients with HCC. Minimally Invasive Therapy & Allied Technologies, 30, 163-168. [Google Scholar] [CrossRef] [PubMed]
[34] Lurje, G., et al. (2018) Prognostic Factors of Disease-Free and Overall Survival in Patients with Hepatocellular Carcinoma Undergoing Partial Hepatectomy in Curative Intent. Langenbeck’s Archives of Surgery, 403, 851-861. [Google Scholar] [CrossRef] [PubMed]
[35] Huang, F. and Gao, J. (2020) Modified Child-Pugh Grade vs Albumin-Bilirubin Grade for Predicting Prognosis of Hepatocellular Carcinoma Patients after Hepatectomy. World Journal of Gastroenterology, 26, 749-758. [Google Scholar] [CrossRef] [PubMed]
[36] Hsu, H.Y., et al. (2017) RAM Score Is an Effective Predictor for Early Mortality and Recurrence after Hepatectomy for Hepatocellular Carcinoma. BMC Cancer, 17, Article No. 742. [Google Scholar] [CrossRef] [PubMed]
[37] Johnson, P.J., et al. (2015) Assessment of Liver Function in Patients with Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade. Journal of Clinical Oncology, 33, 550-558. [Google Scholar] [CrossRef
[38] Wu, B., et al. (2019) Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades for Hepatitis B-Associated Hepatocellular Carcinoma in Child-Pugh A Patients Treated with Radical Surgery: A Retrospective Observational Study. Medicine (Baltimore), 98, e17394. [Google Scholar] [CrossRef
[39] Zhang, J., et al. (2019) The Combination of the Preoperative Albumin-Bilirubin Grade and the Fibrosis-4 Index Predicts the Prognosis of Patients with Hepatocellular Carcinoma after Liver Resection. BioScience Trends, 13, 351-357. [Google Scholar] [CrossRef] [PubMed]
[40] Lin, C.Y., et al. (2020) The ALBI Grade Is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection. World Journal of Surgery, 44, 247-257. [Google Scholar] [CrossRef] [PubMed]
[41] Amisaki, M., et al. (2018) Post-Operative Albumin-Bilirubin Grade Predicts Long-Term Outcomes among Child-Pugh Grade A Patients with Hepatocellular Carcinoma after Curative Resection. Hepatobiliary & Pancreatic Diseases International, 17, 502-509. [Google Scholar] [CrossRef] [PubMed]
[42] Chan, A.W.H., et al. (2018) Development of Pre and Post-Operative Models to Predict Early Recurrence of Hepatocellular Carcinoma after Surgical Resection. Journal of Hepatology, 69, 1284-1293. [Google Scholar] [CrossRef] [PubMed]
[43] He, W., et al. (2018) Nomogram to Predict Survival of Patients with Recurrence of Hepatocellular Carcinoma after Surgery. Clinical Gastroenterology and Hepatology, 16, 756-764.e10. [Google Scholar] [CrossRef] [PubMed]
[44] Shinkawa, H., et al. (2021) Nomograms Predicting Extra- and Early Intrahepatic Recurrence after Hepatic Resection of Hepatocellular Carcinoma. Surgery, 169, 922-928. [Google Scholar] [CrossRef] [PubMed]
[45] Takayama, T., et al. (2021) Prognostic Grade for Resecting Hepatocellular Carcinoma: Multicentre Retrospective Study. British Journal of Surgery, 108, 412-418. [Google Scholar] [CrossRef] [PubMed]
[46] 王清睿, 等. 原发性肝细胞癌切除术后复发的危险因素分析[J]. 疑难病杂志, 2018, 17(7): 706-709.
[47] 梁寻杰, 黄赞松. 术前CRP/Alb、GGT指标的检测对肝细胞癌切除术后早期复发预测价值[J]. 世界华人消化杂志, 2021, 29(17): 999-1005.